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Objective: Although the etiology of schizophrenia is unknown, it has a 
significant genetic component. ‎A number of studies have indicated 
that neuregulin-1 (NRG1) gene may play a role in the ‎pathogenesis of 
schizophrenia. In this study, we examined whether the rs2439272 of 
NRG1 ‎is associated with schizophrenia and its negative symptoms in 
an Iranian population.‎ 
Method: Rs2439272 was genotyped in 469 participants including 276 
unrelated patients with schizophrenia and 193 healthy controls. The 
association of genetic risk with negative ‎symptoms (by using panss) 
was examined in the total, male and female samples. COCAPHASE 
and ‎CLUMP22 programs were used to compare the allele and 
genotype frequencies, and ‎general linear regression was used to 
analyze the quantitative dependent variables by the ‎selected variant.‎ 
Results: In this study, it was revealed that the G allele of rs2439272 
might be an allele with the ‎increased risk of developing schizophrenia, 
especially in the male participants. In addition, ‎significant differences 
were found between the G allele and GG genotype frequencies, and 
negative symptoms in the total and male participants.‎ 
Conclusion: Our results supported the association between 
rs2439272 in NRG1 gene and risk of ‎schizophrenia and its negative 
symptoms in an Iranian population. ‎ 
 
Key words: Negative Symptoms, Neuregulin-1 (NRG1), Positive and 
Negative Syndrome Scale ‎ (PANSS), Schizophrenia, Single Nucleotide 
Polymorphism (SNP) ‎ 
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Schizophrenia (OMIM: 181500) is a severe mental 
disorder, afflicting 1% of the world’s ‎population, and is 
characterized by positive, negative, disorganized and 
cognitive ‎symptoms. Although its etiology is unknown, 
schizophrenia has a significant genetic ‎component. A 
number of studies have indicated that 8p22–p12 is 
likely to harbor ‎schizophrenia susceptibility locus (1-
3). In this region, the candidate gene of interest, ‎NRG1, 
that is involved both in neurodevelopment and 
neurotransmitter mechanisms in ‎the brain, may play a 
role in the pathogenesis of schizophrenia. Stefansson et 
al. (4) ‎reported the over-representation of at-risk 
haplotype (“HapICE”) constructed from five ‎SNPs and 
two microsatellite markers in NRG1 gene for 
schizophrenia in the Icelandic ‎population. Other 
research groups found different haplotypes in different 
ethnic groups ‎ (5-7). Recently, it is reported that 
rs2439272 of NRG1 has significant association 
across ‎working memory domains in schizophrenic 
patients in Asian populations (8). The aim of this ‎study 
was to gain insight into the role of selected SNP and 
schizophrenia and its symptoms ‎in an Iranian 
population. ‎ 
 
Materials and Method 
Participants 
Four hundred sixty nine Iranian participants, including 
276 unrelated patients with ‎schizophrenia and 193 
healthy matched controls, were evaluated. 
Schizophrenia diagnosis ‎was determined independently 
by two expert psychiatrists according to the DSM-IV-
TR ‎criteria. Written informed consent was obtained 
from all participants. This study was ‎approved by the 
Ethics Committees of Tehran University of Medical 
Sciences, Tehran, Iran. ‎Demographic features are 
shown in Table 1.‎ 
 
DNA Preparation, SNPs Selection and Genotyping 
All blood samples were taken by vacuum tube pre-
filled with the anticoagulant EDTA. High ‎molecular 
weight genomic DNA was prepared from venous blood 
using the salting out ‎procedure (9). The SNP 
rs2439272 was selected using the related literature and 
databases ‎ (e.g., UCSC Genome Browser; 
http://genome.ucsc.edu/, SNPper; 
http://snpper.chip.org/, ‎and HapMap; 
http://hapmap.ncbi.nlm.nih.gov/). Genotyping was 
performed blind to ‎status using polymerase chain 
reaction (PCR), and restriction fragment 
length ‎polymorphism-PCR (RFLP-PCR). Primers were 
designed using the Primer3 ‎ 
(http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi). The primers were used 
in the ‎reactions had the following sequences: Forward: 
5′- TTG GCA ATG CAA AAG AAT AG -3′; ‎reverse: 
5′- ACA GCA CAT TTC CTG ATC AG -3′. 
Annealing temperature and PCR product ‎size were 
56ºC and 277 bp, respectively (Figure 1). Restriction 
enzyme was RsaI and ‎corresponding restriction  
 
fragment sizes were 161 bp and 116 bp (Figure 2). 
Number of ‎genotypes callable was 100%, and minor 
allele frequency was greater than 2%. The ‎digested 
fragments were fractionated on 2% agarose gel. 
Furthermore, a random group of ‎samples was also re-
genotyped by direct sequencing to confirm the 
genotyping results of ‎restriction fragment enzyme 
method.‎ 
 
Statistical Analysis 
‎The Hardy–Weinberg equilibrium for genotypic 
distributions in the two populations was ‎tested using 
the χ2 goodness-of-fit test. The allelic association was 
estimated using the ‎COCAPHASED (UNPHASED) 
program (10). The genotype frequencies between cases 
and ‎controls were compared using the CLUMP22 
software (11) by running 1000 Monte 
Carlo ‎simulations. Genotypic association was tested by 
the χ2, or by Fisher’s exact test to assess ‎the 
significance of our results. Independent-samples t-test 
procedure was used to ‎compare the means of the 
quantitative test scores for both groups. General 
linear ‎regression model (Univariate) was utilized to 
analyze a quantitative dependent variable by ‎a single 
independent variable (NRG1 SNP). The significance 
level for all statistical tests was ‎set at P<0.05. ‎ 
 
Results 
Clinical Assessments 
‎We assessed the psychopathology using the PANSS; 
all scores (including positive ‎symptoms, negative 
symptoms, general psychopathology and total score) 
were increased ‎significantly in case vs. control groups 
(P<0.001) )Table 2(.‎ 
 
Marker Analysis for Schizophrenia 
‎We compared the allele and genotype frequencies in 
cases and controls. Using ‎COCAPHASE, we found 
significant differences in allele frequencies between 
cases and ‎controls in total (χ² = 6.711, P = 0.009), and 
in male (χ² = 5.483, P = 0.019) participants (Table ‎3). ‎ 
Using CLUMP22, we found significant differences in 
GG genotype frequencies between ‎cases (0.26) and 
controls (0.16) in total (χ² = 7.730, P = 0.005), and in 
male participants (0.27 ‎in cases vs. 0.15 in controls; χ² 
= 6.273, P = 0.012). No significant differences were 
detected ‎in female participants (Table 4).‎ 
 
Marker Analysis for the PANSS-negative Symptoms 
Our study showed significant differences between 
cases and controls for negative ‎symptoms in total (F = 
3.043, P = 0.029), and male (F = 3.086, P = 0.047) 
participants. No ‎significant differences were detected 
in female patients (Table 5).‎ 
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Table1. Demographic Characteristics of Case and Control Groups 
 
Characteristic Case  Control  Statistics  
 (n = 276) (n = 193) F(P value) 
Sex 
Male, N0 (%)‎ 166 (60%) 122 (63%)  
Female, No (%)‎ 110 (40%) 71 (37%)  
Age (in years) 
Total    
Years (Mean ± SD) 37.32 ± 10.58 37.63 ± 12.32 6.03 (0.83) 
Range, years 18 - 70 18 - 75  
Male    
Years (Mean ± SD) 36.45 ± 10.60 39.23 ± 12.35 2.45 (0.13) 
Range, years 18 - 70 18 - 75  
Female    
Age, years (Mean ± SD) 38.76 ± 10.51 34.67 ± 11.81 2.25 (0.08) 
Range, years 20-67 19 - 60  
Height (in centimeter) 
Total      (Mean ± SD) 166.59 ± 9.47 168.80 ± 7.60 4.77 (0.14) 
Male      (Mean ± SD) 171.34 ± 7.62 171.59 ± 6.02 2.39 (0.87) 
Female  (Mean ± SD) 157.65 ± 5.15 161.50 ± 6.41 0.23 (0.05) 
Handedness 
Total 
Right handed‎ ‎0.87 ‎0.88‎  
Left Handed 0.13 0.12  
‎Male 
Right handed 0.91 0.85  
Left Handed 0.09 0.15  
Female 
‎Right handed 0.81 0.90  
Left Handed 0.19 0.10  
 
 
Table2. Clinical Assessments of psychopathology between case and control groups by using the PANSS 
 
Clinical Assessments (Symptoms) Case  Control Statistics  
 (n = 276) (n = 193) F (P value) 
Total 
PS^ 24.46 ± 4.47 8.04 ± 0.80 57.05 (<0.001*) 
NS^^ 24.47 ± 5.09 8.31 ± 0.97 46.69 (<0.001*) 
GPS^^^ 46.40 ± 6.51 24.12 ± 3.07 13.75 (<0.001*) 
TS^^^^ 95.37 ± 11.58 40.32 ± 3.63 30.99 (<0.001*) 
Male 
PS^ 25.02 ± 4.42 8.11 ± 0.91 33.59 (<0.001*) 
NS^^ 24.72 ± 4.99 8.29 ± 1.04 32.12 (<0.001*) 
GPS^^^ 46.86 ± 6.68 24.22 ± 3.18 8.88 (<0.001*) 
TS^^^^ 96.67 ± 11.40 40.54 ± 3.78 17.08 (<0.001*) 
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Table2 (Continue). Clinical Assessments of psychopathology between case and control groups by using the 
PANSS 
 
Clinical Assessments (Symptoms) Case  Control Statistics  
 (n = 276) (n = 193) F)P value( 
Female 
PS^ 23.62 ± 4.43 7.73 ± 0.54 30.50 (<0.001*) 
NS^^ 24.10 ± 5.25 8.35 ± 0.85 15.76 (<0.001*) 
GPS^^^ 45.70 ± 6.22 23.97 ± 2.90 6.50 (<0.001*) 
TS^^^^ 93.42 ± 11.63 39.93 ± 3.34 17.15 (<0.001*) 
 
^ Positive symptoms  
^^ Negative symptoms  
^^^ General psychopathology symptoms 
^^^^ Total score 
* Significant 
 
 
Table3. Allele frequencies of NRG1 SNP (rs2439272) among cases and controls using COCAPHASE 
 
Alleles Case (number, %) Control (number, %) OR 95%CI χ² P value 
Total (Cases [N=276]; Controls [N=193])    
A 259 (47) 108 (56)     
G 293 (53) 85 (44) 1.412 1.087-1.834 6.711 0.009* 
Male (Cases [N=166]; Controls [N=122])    
A 155 (47) 138 (57)     
G 177 (53) 108 (43) 1.488 1.066-2.073 5.483 0.019* 
Female (Cases [N=110]; Controls [N=71])    
A 105 (48) 77 (54)     
G 115 (52) 65 (46) 1.297 0.850-1.981 1.485 0.23 
 
* Significant
 
 
Table4. Genotype frequencies of NRG1 SNP (rs2439272) among cases and controls using CLUMP22 
 
Alleles Case (number, %) Control (number, %) OR 95%CI χ² P value 
Total (Cases [N=276]; Controls [N=193]) 
AA 50 (20) 52 (27)     
GA 150 (54) 111 (57) 1.278 0.813 - 2.007 1.130 0.29 
GG 71 (26) 30 (16) 2.238 1.264 - 3.960 7.730 0.005* 
GA + GG  221 (80) 141 (73) 1.511 0.938 - 2.431 3.168 0.075** 
Male (Cases [N=166]; Controls [N=122]) 
AA 34 (19) 34 (28)     
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Table4 (Continue). Genotype frequencies of NRG1 SNP (rs2439272) among cases and controls using CLUMP22 
 
GA 87 (52) 70 (57) 1.243 0.703 - 2.198 0.560 0.45 
GG 45 (27) 18 (15) 2.500 1.212 - 5.159 6.273 0.012* 
GA + GG  132 (79) 88 (72) 1.500 0.869 - 2.591 2.127 0.145 
Female (Cases [N=110]; Controls [N=71]) 
AA 21 (22) 18 (25)     
GA 63 (57) 41 (58) 1.317 0.627 - 2.767 0.530 0.47 
GG 26 (24) 12 (17) 1.857 0.733 - 4.705 1.719 0.190 
GA + GG  89 (81) 53 (75) 1.439 0.704 - 2.944 1.001 0.317 
 
 *Significant 
** Trend towards the significant effect 
 
 
 
Table5. The effect of the rs2439272 on PANSS negative test scores in cases and controls: A general linear model analysis 
 
Subjects PANSS-negative (Mean±SD) PANSS-negative (Mean±SD) F P value 
 Case Control   
Total 24.47 ± 5.09 8.31 ± 0.97 3.043 0.029* 
Male 24.72 ± 4.99 8.29 ± 1.04 3.086 0.047* 
Female 24.10 ± 5.25 8.35 ± 0.85 1.135 0.32 
 
* Significant
  
 
 
 
 
 
 
Discussion 
In this study, we examined the association between the 
NRG1 gene selected SNP ‎ (rs2439272) and 
schizophrenia and its negative symptoms in a sample 
of 469 participants, ‎including 276 patients eith 
schizophrenia and 193 normal controls.‎ 
We found that the rs2439272 has a significant effect on 
the risk of developing ‎schizophrenia. This effect was 
found in the total and male samples. Furthermore, 
our ‎study results revealed that the G allele of the 
rs2439272, which is the major allele, might be ‎an allele  
 
with increased risk of developing schizophrenia, 
especially in male patients. ‎ 
Roussos et al. (12) reported the association between 
rs2439272 (G allele) and prepulse ‎inhibition (PPI) of the 
acoustic startle reflex, as a well validated ‎schizophrenia 
endophenotype. However, we could not find any studies 
between ‎rs2439272 and schizophrenia. Mohammad 
Shariati et al (3). in their study, showed a 
significant ‎association between schizophrenia and 
SNP8NRG241930 of NRG1 (located at the 5′ end of ‎this 
277bp 
Figure1. Electrophoresis pattern for the PCR  
 
Figure2. The RFLP pattern of 
RsaI ‎restriction ‎enzyme ‎digestion. 1: Undigested, 
2: ‎homozygous for T/T, ‎3, 4, 6, 7: 
heterozygote ‎for ‎both T/C, 5: homozygous 
for ‎CC. 
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gene) in an Iranian population (3). Most studies have 
found an association between ‎schizophrenia and alleles 
that produce silent changes or occur in non-coding 
regions. It has ‎been shown that these polymorphisms 
(including SNP rs2439272 in our study that are ‎located 
in intronic region), affect NRG1 gene expression. For 
example, the low expression ‎of NRG1 messenger 
ribonucleic acid (mRNA) have been found in the brain 
of patients with schizophrenia (13, 14).‎ 
Neuregulin-1 gene is involved in different 
neurodevelopmental processes (15). It was ‎shown that 
mutations in NRG1 or ErbB (NRG1 receptor) genes 
induce a reduction in the ‎number of interneurons in the 
cortex (16) and hippocampal tissue (17). This gene 
is ‎necessary for establishing excitatory synapses in 
GABAergic interneurons and developing ‎balanced 
excitatory/inhibitory tone in the brain (18, 19). 
Therefore, it can be hypothesized ‎that there is a 
disturbance between excitatory and inhibitory factors, 
and negative ‎symptoms. The association between 
NRG1 and superior temporal gyrus (STG) 
anatomy ‎was explored in patients with schizophrenia. 
It was reported that the right posterior STG ‎had a 
significant positive correlation with negative symptoms 
(20). In their study, Tosato et ‎al. (21) suggested that 
NRG1 may be involved in determining STG size in 
schizophrenia and ‎may be associated with negative 
symptoms. According to the sex specific 
findings ‎between cases and controls, it has been 
suggested that the role of NRG1 may be sex ‎specific in 
regulating some behaviors (22). In animal studies, 
Karatsoreos et al (23). showed the ‎role of ovarian 
hormones to affect corticostrone response to stressors. 
Estrogen has also ‎been shown to modulate both 
excitatory and inhibitory states in neurons (23). It is 
possible ‎that the circulating gonadal hormones 
modulate NRG1-induced changes in 
GABAergic ‎neurotransmission during the development 
and adulthood to produce some of these sex-‎specific 
findings.‎ 
Using the PANSS, we found a significant effect of the 
SNP rs2439272 on negative ‎symptoms especially in 
male patients. Low expression of NRG1 mRNA have 
been found in ‎the brain of patients with schizophrenia 
(13, 14). In a functional study, Zhang et al (24). 
reported an ‎association between the level of NRG1 
mRNA and PANSS ‎scores in a sample of 
schizophrenic patients. Only few studies assessed the 
association ‎between the specific NRG1 variants and 
PANSS test scores in patients with schizophrenia ‎[e.g., 
SNP8NRG241930 with the PANSS cognitive and 
hostility/excitability scores (25)].‎ 
 
Limitations 
There are certain limitations in the present study that 
should be acknowledged. First, the control sample was 
smaller in number than the case sample (193 vs. 276). 
However, our findings could be related to the relatively 
small sample size, so we cannot rule out the possibility 
of false negative findings. Our findings suggest that the 
GG genotype could have increased the risk of 
schizophrenia more than the AA or GA genotypes, 
especially in males. However, we recognize that the 
small sample size in our study limited the ability to draw 
more solid conclusions. Second, is the possible diversity 
in genetic backgrounds of the participants. So, the 
population substructure as a potential source for the 
association could be another limitation in analyses. 
Third, 60% of cases but 63% of controls were male, 
which might have an impact on gender-specific analyses . 
The scope of this study does not permit a detailed 
functional evaluation of the associated SNP. However, 
the future studies are needed to validate the role of the 
NRG1 selected SNP in schizophrenia and its 
psychopathology. 
 
Conclusion 
‎For the first time, we showed that the NRG1 SNP 
(rs2439272 [A/G]) is significantly ‎associated with the 
risk of schizophrenia in an Iranian population. Moreover, 
our results ‎indicated that this SNP is associated with 
negative symptoms. These findings are consistent ‎with 
the theory that indicates NRG-1 gene variants may 
mediate risks for schizophrenia ‎and its negative 
symptoms.‎ 
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